Substituted benzimidazole compounds
US7138420B2 · kind B2 · utility
94Cited by
15References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 1, 2003 |
| Grant date | Nov 21, 2006 |
| Priority date | — |
| Expiry date | Aug 1, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D235/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are substituted benzimidazole compounds of formula (I):wherein R1, R2, R3, R4 and Xa are defined herein. The compounds of the invention inhibit Itk kinase and are therefore useful for treating diseases and pathological conditions involving inflammation, immunological disorders and allergic disorders. Also disclosed are processes for preparing these compounds and to pharmaceutical compositions comprising these compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.